CAPTRUST FINANCIAL ADVISORS - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 40 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q2 2022$040.0%0.00%
Q1 2022$040.0%0.00%
Q4 2021$04
-97.4%
0.00%
Q3 2021$0154
+3750.0%
0.00%
Q2 2021$040.0%0.00%
Q1 2021$040.0%0.00%
Q4 2020$040.0%0.00%
Q3 2020$040.0%0.00%
Q2 2020$040.0%0.00%
Q3 2019$040.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q3 2020
NameSharesValueWeighting ↓
FNY Investment Advisers, LLC 199,220$151,0000.12%
Allred Capital Management, LLC 20,528$15,0000.01%
PATHSTONE FAMILY OFFICE, LLC 10,050$8,0000.00%
LifePlan Financial Group, Inc 1,440$1,0000.00%
VICTORY CAPITAL MANAGEMENT INC 4,806$4,0000.00%
UBS Group AG 105$00.00%
Sowell Financial Services LLC 2,819$2,0000.00%
IFP Advisors, Inc 50$00.00%
OSAIC HOLDINGS, INC. 6$00.00%
Jacobi Capital Management LLC 1,000$1,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders